Although the roles of NRAS G12/G13 mutations in premalignant and malignant settings in CM are largely unknown, we consider that by harnessing the ultrasensitive power of ddPCR, our study provides some updates regarding the molecular alterations present within sun-damaged skin, benign moles, and cutaneous melanomas. This evidence concerns the gene NRAS and cutaneous melanoma.